Kriptazen Brochure
File type: PDF
File size: 1.2 MB
A clever twist in the fight against cryptosporidiosis. Precise dosing for effective results in the management of calf scour.
Kriptazen is a specific, non-antibiotic antiprotozoal oral solution indicated for the prevention and treatment of cryptosporidiosis in calves. It reduces both the intensity of the diarrhoea and the shedding of oocysts, helping to limit environmental contamination. It features an exclusive, twist-adjustable dosing pump designed to ensure accurate dosing, improve treatment compliance, and prevent costly product waste.
Available in Great Britain, Northern Ireland & The Republic of Ireland.
Contact support teams with any question by phone or via our quick form.
Clear, yellow solution. Available in 490ml and 980ml bottles with the dosing pump included. A 980ml refill pack is also available.
Prevention of diarrhoea due to diagnosed Cryptosporidium parvum, in farms with a history of cryptosporidiosis. Administration should start in the first 24 to 48 hours of age.
Reduction of diarrhoea due to diagnosed Cryptosporidium parvum. Administration should start within 24 hours after the onset of diarrhoea.
In both cases, the reduction of oocysts excretion has been demonstrated.
Clinical data demonstrates a strong dose-effect relationship. At the recommended dose, halofuginone provides an optimal balance between high efficacy (reducing oocyst excretion) and allowing the development of the calf’s own natural immunity, without inducing toxicity. Treatment does not completely prevent or cure the disease but significantly reduces oocyst shedding and the duration of diarrhoea.
The active substance, halofuginone, is an antiprotozoal agent of the quinazolinone derivatives group (nitrogenous polyheterocycles). Halofuginone lactate is a salt whose antiprotozoal properties and efficacy against Cryptosporidium parvum have been demonstrated both in in vitro conditions and in artificial and natural infections. The compound has a cryptosporidiostatic effect on Cryptosporidium parvum.
It is mainly active on the free stages of the parasite (sporozoïte, merozoïte). The concentrations to inhibit 50% and 90% of the parasites, in an in vitro test system, are IC50 < 0.1 μg/ml and IC90 of 4.5 μg/ml, respectively.
Halofuginone 0.5mg/ml
For oral use in calves after feeding.
The dosage is: 100 μg of halofuginone/kg by weight (bw), once a day for 7 consecutive days; i.e. 2 ml of veterinary medicinal product/10 kg bw, once a day for 7 consecutive days.
The treatment should be administered at the same time each day. Once the first calf has been treated, all the forthcoming new-born calves must be systematically treated as long as the risk for diarrhoea due to C. parvum persists.
Administration is simplified by an exclusive, adjustable dosing pump graduated from 20 to 60 kg. The pump is designed to be held in one hand, allowing for direct reading of the calf's weight, and delivers the entire required dose in a single press.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Withdrawal periods: Meat and offal: 13 days.
Storage: Keep the bottle in the outer carton in order to protect from light. Store upright in the original packaging.
Shelf Life: Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Shelf life after first opening the immediate packaging: 6 months.
Is there resistance to halofuginone?
No, there are currently no reported cases of halofuginone resistance in C. parvum.
Can calves still test positive on faecal testing to C. parvum when they are on Kriptazen?
Yes. Kriptazen is cryptosporidiostatic, meaning that it does not eliminate infection, but acts to reduce replication of the parasite; reducing the severity of the disease, oocyst excretion and environmental challenge. Faecal samples from infected animals may still therefore test positive for oocysts, but levels will be significantly lower than in untreated calves.
How can I reduce the risk of halofuginone toxicity?
Halofuginone has a low safety index so it is important to dose calves accurately. Kriptazen’s unique pump allows calves to be dosed to the nearest 10Kg, reducing the risk of toxicity but it is important to weigh calves before treating, and to avoid relying on estimated weights. Ensuring calves are not administered Kriptazen on an empty stomach, and that they are dosed at the same time each day also helps calves’ tolerance of halofuginone.
File type: PDF
File size: 1.2 MB